Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 16 studies | 34% ± 15% | |
epithelial cell | 8 studies | 32% ± 14% | |
epithelial cell of proximal tubule | 6 studies | 41% ± 11% | |
enterocyte | 6 studies | 38% ± 10% | |
goblet cell | 4 studies | 24% ± 8% | |
abnormal cell | 4 studies | 22% ± 4% | |
basal cell | 3 studies | 26% ± 12% | |
astrocyte | 3 studies | 22% ± 4% | |
Mueller cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2248.63 | 180 / 180 | 100% | 53.26 | 429 / 430 |
liver | 100% | 4274.30 | 226 / 226 | 100% | 48.43 | 404 / 406 |
thymus | 100% | 5223.36 | 653 / 653 | 99% | 16.93 | 596 / 605 |
esophagus | 100% | 1948.69 | 1445 / 1445 | 98% | 16.11 | 179 / 183 |
prostate | 100% | 3708.53 | 245 / 245 | 98% | 17.81 | 491 / 502 |
intestine | 100% | 3761.09 | 966 / 966 | 98% | 27.37 | 514 / 527 |
stomach | 100% | 2893.62 | 359 / 359 | 97% | 25.19 | 278 / 286 |
kidney | 100% | 5689.26 | 89 / 89 | 97% | 21.99 | 874 / 901 |
uterus | 100% | 2389.10 | 170 / 170 | 96% | 15.98 | 439 / 459 |
bladder | 100% | 1866.43 | 21 / 21 | 96% | 19.69 | 482 / 504 |
brain | 99% | 2968.03 | 2625 / 2642 | 96% | 13.83 | 678 / 705 |
adrenal gland | 100% | 3535.69 | 258 / 258 | 95% | 17.07 | 219 / 230 |
pancreas | 100% | 2712.63 | 328 / 328 | 94% | 18.12 | 168 / 178 |
lung | 99% | 2109.99 | 571 / 578 | 93% | 14.50 | 1078 / 1155 |
breast | 100% | 2361.37 | 459 / 459 | 90% | 15.81 | 1011 / 1118 |
skin | 100% | 2048.56 | 1807 / 1809 | 89% | 10.96 | 418 / 472 |
eye | 0% | 0 | 0 / 0 | 100% | 25.05 | 80 / 80 |
spleen | 100% | 1717.77 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.75 | 1 / 1 |
adipose | 100% | 1864.25 | 1198 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 2814.10 | 849 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1447.52 | 1316 / 1335 | 0% | 0 | 0 / 0 |
muscle | 96% | 1518.33 | 774 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 10.95 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 66% | 5.59 | 19 / 29 |
peripheral blood | 34% | 294.29 | 312 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0005515 | Molecular function | protein binding |
GO_0017020 | Molecular function | myosin phosphatase regulator activity |
Gene name | PPP1R16A |
Protein name | Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3) Protein phosphatase 1 regulatory subunit 16A |
Synonyms | MYPT3 |
Description | FUNCTION: Inhibits protein phosphatase 1 activity toward phosphorylase, myosin light chain and myosin substrates. . |
Accessions | Q96I34 ENST00000529009.1 ENST00000292539.8 A0A087WWZ0 ENST00000435887.2 |